991 related articles for article (PubMed ID: 28662409)
1. Human placental mesenchymal stem cells of fetal origins-alleviated inflammation and fibrosis by attenuating MyD88 signaling in bleomycin-induced pulmonary fibrosis mice.
Li F; Han F; Li H; Zhang J; Qiao X; Shi J; Yang L; Dong J; Luo M; Wei J; Liu X
Mol Immunol; 2017 Oct; 90():11-21. PubMed ID: 28662409
[TBL] [Abstract][Full Text] [Related]
2. [Human placental mesenchymal stem cells of fetal origin relieves mouse pulmonary fibrosis via downregulating MyD88 and TGF-β signaling pathway].
Tao J; Li Q; Ma X; Han F; Liu X; Wei J; Zhu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1347-1351. PubMed ID: 27667460
[TBL] [Abstract][Full Text] [Related]
3. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.
Ortiz LA; Lasky J; Hamilton RF; Holian A; Hoyle GW; Banks W; Peschon JJ; Brody AR; Lungarella G; Friedman M
Exp Lung Res; 1998; 24(6):721-43. PubMed ID: 9839161
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
[TBL] [Abstract][Full Text] [Related]
6. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.
Tashiro J; Elliot SJ; Gerth DJ; Xia X; Pereira-Simon S; Choi R; Catanuto P; Shahzeidi S; Toonkel RL; Shah RH; El Salem F; Glassberg MK
Transl Res; 2015 Dec; 166(6):554-67. PubMed ID: 26432923
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide Combined with Bone Marrow Mesenchymal Stromal Cells Protects against Bleomycin-induced Lung Fibrosis in Mice.
Xu J; Li L; Xiong J; Zheng Y; Ye Q; Li Y
Ann Clin Lab Sci; 2015; 45(3):292-300. PubMed ID: 26116593
[TBL] [Abstract][Full Text] [Related]
9. Phycocyanin attenuates pulmonary fibrosis via the TLR2-MyD88-NF-κB signaling pathway.
Li C; Yu Y; Li W; Liu B; Jiao X; Song X; Lv C; Qin S
Sci Rep; 2017 Jul; 7(1):5843. PubMed ID: 28725012
[TBL] [Abstract][Full Text] [Related]
10. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
[TBL] [Abstract][Full Text] [Related]
11. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.
Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J
J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439
[TBL] [Abstract][Full Text] [Related]
12. Use of tetrandrine to differentiate between mechanisms involved in silica-versus bleomycin-induced fibrosis.
Ma JY; Barger MW; Hubbs AF; Castranova V; Weber SL; Ma JK
J Toxicol Environ Health A; 1999 Jun; 57(4):247-66. PubMed ID: 10406349
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
14. TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis.
Hou J; Ma T; Cao H; Chen Y; Wang C; Chen X; Xiang Z; Han X
J Cell Physiol; 2018 Mar; 233(3):2409-2419. PubMed ID: 28731277
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition.
Li SR; Tan ZX; Chen YH; Hu B; Zhang C; Wang H; Zhao H; Xu DX
Respir Res; 2019 Nov; 20(1):266. PubMed ID: 31775746
[TBL] [Abstract][Full Text] [Related]
16. Naja naja atra venom ameliorates pulmonary fibrosis by inhibiting inflammatory response and oxidative stress.
Cui K; Kou JQ; Gu JH; Han R; Wang G; Zhen X; Qin ZH
BMC Complement Altern Med; 2014 Dec; 14():461. PubMed ID: 25465226
[TBL] [Abstract][Full Text] [Related]
17. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.
Gasse P; Mary C; Guenon I; Noulin N; Charron S; Schnyder-Candrian S; Schnyder B; Akira S; Quesniaux VF; Lagente V; Ryffel B; Couillin I
J Clin Invest; 2007 Dec; 117(12):3786-99. PubMed ID: 17992263
[TBL] [Abstract][Full Text] [Related]
18. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of bleomycin-induced pulmonary fibrosis by bone marrow-derived mesenchymal stem cells might be mediated by decreasing MMP9, TIMP-1, INF-γ and TGF-β.
Yu SH; Liu LJ; Lv B; Che CL; Fan DP; Wang LF; Zhang YM
Cell Biochem Funct; 2015 Aug; 33(6):356-66. PubMed ID: 26178702
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
